California
Duarte; City of Hope
PHII-80 PHL-051 NCI #7502: A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Duarte; City of Hope
A Randomized 2-Arm, Open Label, Phase II Study of BMS-582664, Administered Orally at a Dose of 800mg Daily or Doxorubicin Administered Intravenously at a Dose of 60mg/m2 Every 3 Weeks in Patients with Unsectable, Locally Advanced or Metastatic Hepatocellular Carcinoma
Florida
Aventura; South Florida Medical Research
Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease
Gainesville; Gainesville Hematology/ Oncology Associates
A Randomized Phase III Trial of Cetuximab, Bevacizumab and Biweekly Infusional 5-FU/Leucovorin (FOLF-CB) versus Oxaliplatin, Bevacizumab, and Biweekly Infusional 5-FU/Leucovorin (Bev-FOLFOX) in First-line Treatment of Metastatic Colorectal Cancer
Indiana
Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase III; First Line Treatment
Study of Taxoprexin Injection vs. study drug in Patients with Metastatic Melanoma
Massachusetts
Boston; Dana Farber Cancer Institute
An open-label dose escalation study of patients with solid tumors treated with STA-9090
Boston; Dana Farber Cancer Institute
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
Michigan
Detroit; Wayne State University Karmanos Cancer Institute
An open-label dose escalation study of patients with solid tumors treated with STA-9090
Detroit; Wayne State University Karmanos Cancer Institute
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
New York
Manhasset; Biomedical Research Alliance of New York
Metastatic Cancer to the Brain - Adults
New York; Columbia-Presbyterian Medical Center
A phase II study of combination therapy of a protracted oral schedule of temozolomide and thalidomide as first-line or subsequent therapy for patients with metastatic, locally advanced or unresectable leiomyosarcoma.
International
Various Cities, Germany; Research Sites
This is a multi-national, double-blind, placebo controlled study in patients with locally advanced or metastatic breast cancer.
Various Cities, Italy; Research Sites
This is a multi-national, double-blind, placebo controlled study in patients with locally advanced or metastatic breast cancer.
Various Cities, Poland; Research Sites
This is a multi-national, double-blind, placebo controlled study in patients with locally advanced or metastatic breast cancer.
Various Cities, Russia; Research Sites
This is a multi-national, double-blind, placebo controlled study in patients with locally advanced or metastatic breast cancer.
